| Name |
Zexyden 4 mg tablete |
| Marketing Authorisation Number |
HR-H-952761759 |
| Active Substance |
deksametazon |
| Composition |
jedna tableta sadrži 4 mg deksametazona |
| Pharmaceutical Form |
Tableta |
| Manufacturer |
Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder |
Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date |
27.03.2024 |
| MA Period of Validity |
27.03.2029 |
| Classification Number |
UP/I-530-09/22-01/221 |
| Registration Number |
381-12-01/70-24-15 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
H02AB02 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
